Product Information
OXYBUTYNIN CL ER 10 MG TABLET is a generic product labeled by Accord Healthcare Inc., priced at $0.1027 per EA under NDC 16729031801. Its NADAC has been published 496 times since Jan 4, 2017.
FDA first approved this application on Feb 29, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Accord Healthcare Inc.NDC
16729031801
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
6/17/2026
Active Ingredients
OXYBUTYNIN CHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207138FDA Approved
2/29/2016
TE Code
AB
On Market Since
12/20/2016
Pharmacological Classes
Price Statistics
The NADAC for OXYBUTYNIN CL ER 10 MG TABLET has been published 496 times since Jan 4, 2017, and over the history we have for it it has declined 84.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1027 per EA |
|---|---|
| All-time high | $0.6678 (Jan 11, 2017) |
| All-time low | $0.0837 (Nov 20, 2024) |
| 52-week high | $0.1089 |
| 52-week low | $0.1011 |
| Median price | $0.1984 |
| Average price | $0.2406 |
| Largest weekly change | +35.2% (Jun 19, 2024) |
| Weeks tracked | 496 |
| Tracking since | Jan 4, 2017 |
1W
N/A
1M
N/A
3M
-0.3%
6M
-1.6%
1Y
-4.6%
3Y
-10.0%
5Y
-47.0%
All
-84.6%
Last surveyed Jul 1, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of OXYBUTYNIN CL ER 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OXYBUTYNIN CL ER 10 MG TABLET, manufactured by Accord Healthcare Inc., is $0.1027 per EA (NDC 16729031801), effective Jul 1, 2026.
How has the price of OXYBUTYNIN CL ER 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for OXYBUTYNIN CL ER 10 MG TABLET has declined 84.6%. It has been tracked across 496 weekly CMS publications since Jan 4, 2017.
What are the highest and lowest recorded NADAC prices for OXYBUTYNIN CL ER 10 MG TABLET?
Since Jan 4, 2017, the NADAC for OXYBUTYNIN CL ER 10 MG TABLET has ranged from a low of $0.0837 (Nov 20, 2024) to a high of $0.6678 (Jan 11, 2017), with a median of $0.1984 per EA.
Are there cheaper alternatives to OXYBUTYNIN CL ER 10 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as OXYBUTYNIN CL ER 10 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures OXYBUTYNIN CL ER 10 MG TABLET?
OXYBUTYNIN CL ER 10 MG TABLET (NDC 16729031801) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.